Home
Bios Equity Partners II, 10% Owner: Lantern Pharma LTRN Sell · Filed 25/06/13
Trade details
- Type
- Insider sale
- Amount
- $72,862.66
- Shares · price
- 21,557 sh · $3.38 a share
- Held after
- 387,396 sh
- Stock
- Lantern Pharma LTRN
- Trade date
- 25/06/12
- Filed
- 25/06/13
- Days to filing
- 1 days
Sold 5.3% of holdings
- Share of holding sold
- 5.3%
Lantern Pharma trades, last 26 weeks
What else happened in Lantern Pharma around then
Filed or reported within 30 days of the trade day · 25/05/13~25/07/12Bios Equity Partners II's recent trades
- Bios Equity Partners II
BuyActuate Therapeutics
BuyActuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
- Bios Equity Partners II
SellLantern Pharma
SellLantern Pharma
LTRN
$43.9K
14,218 sh
$43.9K
Filed 25/06/13
Traded 25/06/13
- Bios Equity Partners II
SellLantern Pharma
SellLantern Pharma
LTRN
$38.1K
12,319 sh
$38.1K
Filed 25/06/13
Traded 25/06/13
- Bios Equity Partners II
SellLantern Pharma
SellLantern Pharma
LTRN
$22.3K
7,206 sh
$22.3K
Filed 25/06/13
Traded 25/06/13
- Bios Equity Partners II
SellLantern Pharma
SellLantern Pharma
LTRN
$13.5K
4,354 sh
$13.5K
Filed 25/06/13
Traded 25/06/13
